Reconnect Labs develops next-gen psychedelic medicines for neuropsychiatry.
Reconnect Labs has raised $11.0M in total funding. The most recent round was Grant. The last funding was announced in January 2025.
Reconnect Labs is headquartered in Zürich, Switzerland.
Reconnect Labs develops next-gen psychedelic medicines for neuropsychiatry.
Reconnect Labs is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reconnect Labs — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/reconnect-labs. Accessed August 15, 2026.
VCBacked. (2025). Reconnect Labs — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/reconnect-labs
{{cite web |title=Reconnect Labs — Funding & Investors |url=https://www.vcbacked.co/company/reconnect-labs |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated